NurExone Announces Closing of Second Tranche of Private Placement, bringing total raise at this round to approximately CAD$1.5M
“I am pleased with the outcome of our Private Placement and on behalf of NurExone’s team, I would like to thank our investors and shareholders for the support and trust in the Company and its team”, said Dr. Lior Shaltiel, CEO of NurExone. Read More >>>
September 7, 2023